These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27568110)

  • 1. Amiodarone or nifekalant upon hospital arrival for refractory ventricular fibrillation after out-of-hospital cardiac arrest.
    Tagami T; Matsui H; Ishinokami S; Oyanagi M; Kitahashi A; Fukuda R; Unemoto K; Fushimi K; Yasunaga H
    Resuscitation; 2016 Dec; 109():127-132. PubMed ID: 27568110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiodarone Compared with Lidocaine for Out-Of-Hospital Cardiac Arrest with Refractory Ventricular Fibrillation on Hospital Arrival: a Nationwide Database Study.
    Tagami T; Matsui H; Tanaka C; Kaneko J; Kuno M; Ishinokami S; Unemoto K; Fushimi K; Yasunaga H
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):485-491. PubMed ID: 27618826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of nifekalant and amiodarone for resuscitation of out-of-hospital cardiopulmonary arrest resulting from shock-resistant ventricular fibrillation.
    Harayama N; Nihei S; Nagata K; Isa Y; Goto K; Aibara K; Kamochi M; Sata T
    J Anesth; 2014 Aug; 28(4):587-92. PubMed ID: 24389941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.
    Kudenchuk PJ; Brown SP; Daya M; Rea T; Nichol G; Morrison LJ; Leroux B; Vaillancourt C; Wittwer L; Callaway CW; Christenson J; Egan D; Ornato JP; Weisfeldt ML; Stiell IG; Idris AH; Aufderheide TP; Dunford JV; Colella MR; Vilke GM; Brienza AM; Desvigne-Nickens P; Gray PC; Gray R; Seals N; Straight R; Dorian P;
    N Engl J Med; 2016 May; 374(18):1711-22. PubMed ID: 27043165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of nifekalant and lidocaine for the treatment of shock-refractory ventricular fibrillation.
    Tahara Y; Kimura K; Kosuge M; Ebina T; Sumita S; Hibi K; Toyama H; Kosuge T; Moriwaki Y; Suzuki N; Sugiyama M; Umemura S
    Circ J; 2006 Apr; 70(4):442-6. PubMed ID: 16565562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nifekalant Versus Amiodarone in the Treatment of Cardiac Arrest: an Experimental Study in a Swine Model of Prolonged Ventricular Fibrillation.
    Karlis G; Iacovidou N; Lelovas P; Niforopoulou P; Papalois A; Siafaka I; Mentzelopoulos S; Xanthos T
    Cardiovasc Drugs Ther; 2015; 29(5):425-31. PubMed ID: 26145169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation.
    Kudenchuk PJ; Cobb LA; Copass MK; Cummins RO; Doherty AM; Fahrenbruch CE; Hallstrom AP; Murray WA; Olsufka M; Walsh T
    N Engl J Med; 1999 Sep; 341(12):871-8. PubMed ID: 10486418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nifekalant Hydrochloride and Amiodarone Hydrochloride Result in Similar Improvements for 24-Hour Survival in Cardiopulmonary Arrest Patients: The SOS-KANTO 2012 Study.
    Amino M; Inokuchi S; Nagao K; Nakagawa Y; Yoshioka K; Ikari Y; Funakoshi H; Hayakawa K; Matsuzaki M; Sakurai A; Tahara Y; Yonemoto N; Yaguchi A; Morimura N;
    J Cardiovasc Pharmacol; 2015 Dec; 66(6):600-9. PubMed ID: 26317166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug Therapy for Shock-Resistant Ventricular Fibrillation: Comparison of Nifekalant and Amiodarone].
    Harayama N; Nihei S; Nagata K; Aibara K; Kamochi M; Sata T
    J UOEH; 2016 Mar; 38(1):35-46. PubMed ID: 26972943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hospital administration of amiodarone and/or lidocaine in shockable patients presenting with out-of-hospital cardiac arrest: A nationwide cohort study.
    Huang CH; Yu PH; Tsai MS; Chuang PY; Wang TD; Chiang CY; Chang WT; Ma MH; Tang CH; Chen WJ
    Int J Cardiol; 2017 Jan; 227():292-298. PubMed ID: 27843049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of Nifekalant hydrochloride for life-threatening ventricular tachyarrhythmias in patients with resistance to lidocaine: a study of patients with out-of-hospital cardiac arrest].
    Amino M; Yoshioka K; Iwata O; Fujikura H; Deguchi Y; Ban K; Shiina Y; Goto S; Handa S; Tanabe T; Nakagawa Y; Morita S; Iwase H; Yamamoto I; Inokuchi S; Marutani Y
    J Cardiol; 2003 Mar; 41(3):127-34. PubMed ID: 12674997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of nifekalant versus amiodarone for shock-resistant ventricular fibrillation in out-of-hospital cardiopulmonary arrest patients.
    Amino M; Yoshioka K; Opthof T; Morita S; Uemura S; Tamura K; Fukushima T; Higami S; Otsuka H; Akieda K; Shima M; Fujibayashi D; Hashida T; Inokuchi S; Kodama I; Tanabe T
    J Cardiovasc Pharmacol; 2010 Apr; 55(4):391-8. PubMed ID: 20147846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy of nifekalant and amiodarone in a porcine model of cardiac arrest.
    Ji XF; Li CS; Wang S; Yang L; Cong LH
    Resuscitation; 2010 Aug; 81(8):1031-6. PubMed ID: 20627529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation.
    Dorian P; Cass D; Schwartz B; Cooper R; Gelaznikas R; Barr A
    N Engl J Med; 2002 Mar; 346(12):884-90. PubMed ID: 11907287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nifekalant versus Amiodarone for Out-Of-Hospital Cardiac Arrest with Refractory Shockable Rhythms; a Post Hoc Analysis.
    Funakoshi H; Aso S; Homma Y; Onodera R; Tahara Y
    Arch Acad Emerg Med; 2022; 10(1):e6. PubMed ID: 35072095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of nifekalant hydrochloride in the treatment of fatal ventricular arrhythmia in patients with ischemic heart disease.
    Ando J; Kakishita M; Sakai K; Komura Y; Nishiyama K; Iwabuchi M; Yokoi H; Yasumoto H; Nosaka H; Nobuyoshi M
    Int Heart J; 2005 Jul; 46(4):647-56. PubMed ID: 16157956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs in cardiac arrest: the rise and fall of antiarrhythmics.
    Karlis G; Afantenou S
    Acta Cardiol; 2018 Aug; 73(4):325-327. PubMed ID: 29025372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia.
    Shiga T; Tanaka K; Kato R; Amino M; Matsudo Y; Honda T; Sagara K; Takahashi A; Katoh T; Urashima M; Ogawa S; Takano T; Kasanuki H;
    Resuscitation; 2010 Jan; 81(1):47-52. PubMed ID: 19913983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation.
    Valdes SO; Donoghue AJ; Hoyme DB; Hammond R; Berg MD; Berg RA; Samson RA;
    Resuscitation; 2014 Mar; 85(3):381-6. PubMed ID: 24361455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amiodarone Versus Lidocaine for Pediatric Cardiac Arrest Due to Ventricular Arrhythmias: A Systematic Review.
    McBride ME; Marino BS; Webster G; Lopez-Herce J; Ziegler CP; De Caen AR; Atkins DL
    Pediatr Crit Care Med; 2017 Feb; 18(2):183-189. PubMed ID: 28009655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.